BioXcel Therapeutics, Inc. Other Interest and Dividend Income
BioXcel Therapeutics, Inc. (BTAI) reported Other Interest and Dividend Income of $155.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherInterestAndDividendIncome · last filed 2021-03-12
- BioXcel Therapeutics, Inc. other interest and dividend income for the quarter ending 2020-12-31 was $15.00K, a 86.49% decline year-over-year.
- BioXcel Therapeutics, Inc. other interest and dividend income for the quarter ending 2020-09-30 was $20.00K, a 85.07% decline year-over-year.
- BioXcel Therapeutics, Inc. other interest and dividend income for the quarter ending 2019-12-31 was $111.00K.
- BioXcel Therapeutics, Inc. other interest and dividend income for the quarter ending 2019-09-30 was $134.00K.
- BioXcel Therapeutics, Inc. other interest and dividend income for fiscal 2020 was $155.00K, a 76.26% decline from fiscal 2019.
- BioXcel Therapeutics, Inc. other interest and dividend income for fiscal 2019 was $653.00K.
| Period end | Other Interest and Dividend Income 3 month | Other Interest and Dividend Income 6 month | Other Interest and Dividend Income 9 month | Other Interest and Dividend Income 12 month |
|---|---|---|---|---|
| 2020-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $35.00K derived: sum of 2 quarters · filed 2021-03-12 | $155.00K 10-K · filed 2021-03-12 | |
| 2020-09-30 | $20.00K 10-Q · filed 2020-11-12 | $140.00K 10-Q · filed 2020-11-12 | ||
| 2019-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $245.00K derived: sum of 2 quarters · filed 2021-03-12 | $653.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $134.00K 10-Q · filed 2020-11-12 | $542.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |